Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

386 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 386 results

Testing effectiveness (Phase 2)Study completedNCT01519414
What this trial is testing

Tivantinib in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053152
What this trial is testing

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Who this might be right for
Oligometastatic Prostate CarcinomaProstate AdenocarcinomaProstate Ductal Adenocarcinoma+2 more
NRG Oncology 194
Testing effectiveness (Phase 2)Study completedNCT00020735
What this trial is testing

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Joel Nelson, MD 45
Testing effectiveness (Phase 2)Ended earlyNCT00006371
What this trial is testing

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)UnknownNCT02525068
What this trial is testing

Enzalutamide in Combination With AZD5363 in Patients With mCRPC

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 136
Testing effectiveness (Phase 2)Study completedNCT02203695
What this trial is testing

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 86
Testing effectiveness (Phase 2)Study completedNCT00003124
What this trial is testing

Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Herbert Irving Comprehensive Cancer Center 105
Testing effectiveness (Phase 2)Study completedNCT00020046
What this trial is testing

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00006359
What this trial is testing

Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 63
Testing effectiveness (Phase 2)Ended earlyNCT00521781
What this trial is testing

Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 14
Testing effectiveness (Phase 2)Study completedNCT00020254
What this trial is testing

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT02346253
What this trial is testing

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Stanford University 146
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableEnded earlyNCT02024685
What this trial is testing

Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial

Who this might be right for
Adenocarcinoma of ProstateAdenocarcinoma of the Prostate Stage IAdenocarcinoma of the Prostate Stage II+1 more
Case Comprehensive Cancer Center 76
Testing effectiveness (Phase 2)Study completedNCT00060437
What this trial is testing

Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT01682772
What this trial is testing

TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 148
Testing effectiveness (Phase 2)WithdrawnNCT00003517
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage III Prostate CancerStage IV Prostate Cancer+1 more
Burzynski Research Institute
Large-scale testing (Phase 3)UnknownNCT00567580
What this trial is testing

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,792
Testing effectiveness (Phase 2)Temporarily pausedNCT04519879
What this trial is testing

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Who this might be right for
Prostate AdenocarcinomaPSA FailurePSA Progression+7 more
City of Hope Medical Center 133
Testing effectiveness (Phase 2)Study completedNCT00151086
What this trial is testing

Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 33
Next Page